FBRX insider transaction filings
Forte Biosciences, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-27. Screen FBRX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 11 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 68.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Riley Antony A — CHIEF FINANCIAL OFFICER | 2 | — | — | 15 |
| Wagner Paul A. — SEE REMARKS, Director | 2 | — | — | 14 |
| Kornfeld Steven — Director | 1 | — | — | 9 |
| FINCK BARBARA K — Director | 1 | — | — | 7 |
| Doberstein Stephen K — Director | 1 | — | — | 6 |
| GRYSKA DAVID W — Director | 1 | — | — | 6 |
| Brun Scott C. — Director | 1 | — | — | 5 |
| Kapoor Shivpreet Singh — Director | 1 | — | — | 3 |
| VINCENT RICHARD G — Director | 1 | — | — | 3 |
Recent Form 4 filings — Forte Biosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | Kornfeld Steven — Director | Code (U): 3,960 · Disposition to issuer (D): 1,200 (derivative) · Disposition to issuer (D): 800 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · +3 more | EDGAR |
| 2026-08-27 | 4 | FINCK BARBARA K — Director | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 166 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 7,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · +1 more | EDGAR |
| 2026-08-27 | 4 | VINCENT RICHARD G — Director | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative) | EDGAR |
| 2026-08-27 | 4 | GRYSKA DAVID W — Director | Code (U): 5,940 · Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative) | EDGAR |
| 2026-08-27 | 4 | Brun Scott C. — Director | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative) | EDGAR |
| 2026-08-27 | 4 | Wagner Paul A. — SEE REMARKS, Director | Code (U): 85,482 · Disposition to issuer (D): 16,866 (derivative) · Disposition to issuer (D): 5,400 (derivative) · Disposition to issuer (D): 11,999 (derivative) · Disposition to issuer (D): 44,000 (derivative) · Disposition to issuer (D): 920,000 (derivative) · +5 more | EDGAR |
| 2026-08-27 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Code (U): 42,600 · Disposition to issuer (D): 421 (derivative) · Disposition to issuer (D): 2,999 (derivative) · Disposition to issuer (D): 1,700 (derivative) · Disposition to issuer (D): 2,999 (derivative) · Disposition to issuer (D): 14,000 (derivative) · +6 more | EDGAR |
| 2026-08-27 | 4 | Doberstein Stephen K — Director | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 1,000 (derivative) · Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative) | EDGAR |
| 2026-08-27 | 4 | Kapoor Shivpreet Singh — Director | Disposition to issuer (D): 2,000 (derivative) · Disposition to issuer (D): 31,000 (derivative) · Disposition to issuer (D): 18,353 (derivative) | EDGAR |
| 2026-07-06 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 · Tax withholding (F): 98 @ $21.32 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 · Tax withholding (F): 134 @ $21.32 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Wagner Paul A. — SEE REMARKS, Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Kapoor Shivpreet Singh — Director | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Brun Scott C. — Director | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Kornfeld Steven — Director | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Doberstein Stephen K — Director | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | VINCENT RICHARD G — Director | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | GRYSKA DAVID W — Director | Grant/award (A): 18,353 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 · Tax withholding (F): 98 @ $24.86 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 · Tax withholding (F): 134 @ $24.86 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Wagner Paul A. — SEE REMARKS, Director | Grant/award (A): 270,000 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $27.27 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Purchase (P): 9,680 @ $26.33 · Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $27.27 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $14.52 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 @ $0 · Tax withholding (F): 134 @ $14.52 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $12.44 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 @ $0 · Tax withholding (F): 134 @ $12.44 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 18 @ $7.43 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $7.43 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Kapoor Shivpreet Singh — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Doberstein Stephen K — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Brun Scott C. — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Kornfeld Steven — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Wagner Paul A. — SEE REMARKS, Director | Grant/award (A): 920,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Grant/award (A): 323,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | VINCENT RICHARD G — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | FINCK BARBARA K — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | GRYSKA DAVID W — Director | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $22.71 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 @ $0 · Tax withholding (F): 154 @ $22.71 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2024-11-22 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Purchase (P): 22,514 @ $5.55 | EDGAR |
| 2024-10-02 | 4 | Wagner Paul A. — SEE REMARKS, Director | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $5.16 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Riley Antony A — CHIEF FINANCIAL OFFICER | Option exercise (M): 375 @ $0 · Tax withholding (F): 133 @ $5.16 · Option exercise (M): 375 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | Kapoor Shivpreet Singh — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | VINCENT RICHARD G — Director | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Brun Scott C. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | FINCK BARBARA K — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | GRYSKA DAVID W — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Forte Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-27 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-01 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FBRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →